2019
DOI: 10.1016/j.foodres.2018.08.029
|View full text |Cite
|
Sign up to set email alerts
|

Influence of the in vitro gastrointestinal digestion on the antioxidant activity of Artemisia gorgonum Webb and Hyptis pectinata (L.) Poit. infusions from Cape Verde

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
19
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 42 publications
0
19
0
Order By: Relevance
“…Despite the reducing effect of digestion phases on the phenolic content and activity of A. frigida herbal tea, the final levels of antioxidant activity remained high because of the appropriate content of bioactive components. Earlier data about in vitro digestion of Artemisia gorgonum Webb infusion also demonstrated a reduction of the phenolic compound content, but FRAP, CUPRAC and other antioxidant parameters were high after gastric and intestinal media treatment [70]. Despite the limited data on the digestive stability of Artemisia , one can assume that the antioxidant capacity of Artemisia extracts remains high because of their high hydroxycinnamate content.…”
Section: Resultsmentioning
confidence: 99%
“…Despite the reducing effect of digestion phases on the phenolic content and activity of A. frigida herbal tea, the final levels of antioxidant activity remained high because of the appropriate content of bioactive components. Earlier data about in vitro digestion of Artemisia gorgonum Webb infusion also demonstrated a reduction of the phenolic compound content, but FRAP, CUPRAC and other antioxidant parameters were high after gastric and intestinal media treatment [70]. Despite the limited data on the digestive stability of Artemisia , one can assume that the antioxidant capacity of Artemisia extracts remains high because of their high hydroxycinnamate content.…”
Section: Resultsmentioning
confidence: 99%
“…The FRAP assay was performed following the procedure described by Lima et al [27]. Briefly, 3.0 mL of freshly prepared and pre-warmed at 37 • C FRAP reagent (20 mL of 10 mM TPTZ solution in 40 mM HCl and 20 mL of 20 mM ferric chloride in 200 mL of 0.25 M sodium acetate buffer, pH 3.6) and 400 µL of each sample were mixed, and the absorbance of the resulting mixture was measured using a UV/VIS spectrophotometer (SPEKOL 1500, Analytik Jena, Germany) at 593 nm, after 4 min incubation at 37 • C. A calibration curve of ferrous sulphate was used and results were expressed as mmol Fe 2+ equivalents per gram of dry extract.…”
Section: Ferric Reducing Antioxidant Power (Frap) Assaymentioning
confidence: 99%
“…Moreover, in vitro and in vivo studies demonstrate their capacity in the prevention of cardiovascular and type 2 diabetes risk factors by exerting a strong anti-hypertensive effect, lowering cholesterol level, ameliorating insulin resistance, and improving lipid profile in high-fat diet treated rats [24][25][26][27][28].However, it is well known that all these health benefits can occur only if the putatively active compounds are bioavailable. Bioavailability is markedly affected by bioaccessibility, i.e., the release of compounds after their intake with food, and by the chemical transformations occurring during gastrointestinal metabolism (digestibility factor) [29,30]; therefore, the evaluation of these two parameters is mandatory in order to adequately investigate the effectiveness of bioactive molecules in vitro [31,32].Recently, FlaNat Research Italia Srl (Rho, MI, Italy) developed a new Italian purple corn variety, named Moradyn, which is able to sprout and grow in northern Italy, maintaining a highly pigmented cob. Thus, the aim of the present work is to investigate the health properties of Moradyn phytocomplex cob extract (CE), compared with its purified anthocyanin fraction (AF).…”
mentioning
confidence: 99%
“…However, it is well known that all these health benefits can occur only if the putatively active compounds are bioavailable. Bioavailability is markedly affected by bioaccessibility, i.e., the release of compounds after their intake with food, and by the chemical transformations occurring during gastrointestinal metabolism (digestibility factor) [29,30]; therefore, the evaluation of these two parameters is mandatory in order to adequately investigate the effectiveness of bioactive molecules in vitro [31,32].…”
mentioning
confidence: 99%